In order to confirm this, expression levels of IGF2 protein levels in breast cancer cells with or without CD44+Fbs or CD44−Fbs were examined by Western blotting and IGF2 indeed expressed much higher in breast cancer cells cocultured with CD44+Fbs than with CD44−Fbs. Here, CD44 is linked to breast carcinoma.